Search research articles
Contact Us
Filters
Showing results (11-20 of 57) with videos related to
Page
of 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
April 20, 2005
A coiled-coil interaction mediates cauliflower mosaic virus cell-to-cell movement
Livia Stavolone, Maria Elena Villani, Denis Leclerc, et al.
Journal of Virology
|
November 9, 2007
Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation
Patrick Lacasse, Jérôme Denis, Réjean Lapointe, et al.
Journal of Virology
|
October 22, 2002
Mutation of capsid protein phosphorylation sites abolishes cauliflower mosaic virus infectivity
Yvan Chapdelaine, David Kirk, Aletta Karsies, et al.
Plos One
|
October 8, 2013
A novel M2e based flu vaccine formulation for dogs
Denis Leclerc, Marie Rivest, Cindy Babin, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|
April 28, 2007
Effect of cAMP-dependent protein kinase A (PKA) on HCV nucleocapsid assembly and degradation
Nathalie Majeau, Marilène Bolduc, Jean-Baptiste Duvignaud, et al.
The Journal of General Virology
|
June 21, 2002
Regulated nuclear targeting of cauliflower mosaic virus
Aletta Karsies, Thomas Merkle, Boris Szurek, et al.
The Journal of Biological Chemistry
|
September 29, 2009
Palmitoylation of hepatitis C virus core protein is important for virion production
Nathalie Majeau, Rémi Fromentin, Christian Savard, et al.
Molecular Immunology
|
September 23, 2011
IDO expression by human B lymphocytes in response to T lymphocyte stimuli and TLR engagement is biologically inactive
Jessica Godin-Ethier, Laïla-Aïcha Hanafi, Jean-Baptiste Duvignaud, et al.
Nano Letters
|
February 19, 2016
Potentiating Cancer Immunotherapy Using Papaya Mosaic Virus-Derived Nanoparticles
Marie-Ève Lebel, Karine Chartrand, Esther Tarrab, et al.
Frontiers in Immunology
|
January 23, 2018
Efficacy of a Virus-Like Nanoparticle As Treatment for a Chronic Viral Infection Is Hindered by IRAK1 Regulation and Antibody Interference
Karine Chartrand, Marie-Ève Lebel, Esther Tarrab, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 57) with videos related to
Sort By:
Page
of 6
Proceedings of the National Academy of Sciences of the United States of America
|
April 20, 2005
A coiled-coil interaction mediates cauliflower mosaic virus cell-to-cell movement
Livia Stavolone, Maria Elena Villani, Denis Leclerc, et al.
Journal of Virology
|
November 9, 2007
Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation
Patrick Lacasse, Jérôme Denis, Réjean Lapointe, et al.
Journal of Virology
|
October 22, 2002
Mutation of capsid protein phosphorylation sites abolishes cauliflower mosaic virus infectivity
Yvan Chapdelaine, David Kirk, Aletta Karsies, et al.
Plos One
|
October 8, 2013
A novel M2e based flu vaccine formulation for dogs
Denis Leclerc, Marie Rivest, Cindy Babin, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|
April 28, 2007
Effect of cAMP-dependent protein kinase A (PKA) on HCV nucleocapsid assembly and degradation
Nathalie Majeau, Marilène Bolduc, Jean-Baptiste Duvignaud, et al.
The Journal of General Virology
|
June 21, 2002
Regulated nuclear targeting of cauliflower mosaic virus
Aletta Karsies, Thomas Merkle, Boris Szurek, et al.
The Journal of Biological Chemistry
|
September 29, 2009
Palmitoylation of hepatitis C virus core protein is important for virion production
Nathalie Majeau, Rémi Fromentin, Christian Savard, et al.
Molecular Immunology
|
September 23, 2011
IDO expression by human B lymphocytes in response to T lymphocyte stimuli and TLR engagement is biologically inactive
Jessica Godin-Ethier, Laïla-Aïcha Hanafi, Jean-Baptiste Duvignaud, et al.
Nano Letters
|
February 19, 2016
Potentiating Cancer Immunotherapy Using Papaya Mosaic Virus-Derived Nanoparticles
Marie-Ève Lebel, Karine Chartrand, Esther Tarrab, et al.
Frontiers in Immunology
|
January 23, 2018
Efficacy of a Virus-Like Nanoparticle As Treatment for a Chronic Viral Infection Is Hindered by IRAK1 Regulation and Antibody Interference
Karine Chartrand, Marie-Ève Lebel, Esther Tarrab, et al.
Page
of 6